It has been reported that S1P1 agonist LAS1238 significantly reduced infarct volume of mice model after ischemia/reperfusion, indicating S1P1 is potential target for ischemic stroke treatment (Brait et al., 2016). The gene discussed is S1PR1; the disease is ischemia.